Apotex introduces IVRA (Melphalan) hydrochloride injection: First ready to dilute liquid formulation of Melphalan injection approved via 505(b)(2) NDA WESTON, Fla., May 9, 2025 /PRNewswire/ - Apotex Corp. today launched IVRA (Melphalan) hydrochloride injection 90mg/ml multidose vial ("IVRA"), first ready-to-dilute liquid formulation of Melphalan injection approved via 505(b)(2) NDA ... $$ djournal.com djournal.com / feeds djournal-com-news-nation-world / / #news / / 21 days 21d Share
